戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 orce-dependent kinetics of dissociation from intercellular adhesion molecule 1.
2 kocyte-endothelial adhesion via induction of intercellular adhesion molecule 1.
3 d leukocyte adhesion via the EC induction of intercellular adhesion molecule 1.
4 gands, vascular cell adhesion molecule 1 and intercellular adhesion molecule 1.
5 phages adhere to the beta(2) integrin ligand intercellular adhesion molecule-1.
6 senting cells was predominantly dependent on intercellular adhesion molecule-1.
7 n-6, vascular endothelial growth factor, and intercellular adhesion molecule-1.
8 "nonsticky" antigen-presenting cells lacking intercellular adhesion molecule-1.
9 complement fragments iC3b and C3d but not to intercellular adhesion molecule-1.
10 ectin, retinol-binding protein 4) or soluble intercellular adhesion molecule-1.
11 creased vascular inflammation marker soluble intercellular adhesion molecule-1 (-10%, P < 0.01).
12     The major ligands of LFA-1 include three intercellular adhesion molecules 1, 2, and 3 (ICAM 1, 2,
13 ed to the nucleus, and expression of ICAM-1 (intercellular adhesion molecule-1), a transcriptional pr
14                                Deficiency of intercellular adhesion molecule 1, a counter-receptor fo
15 r CD40L, CD28, and LFA-1 (CD40, CD80/86, and intercellular adhesion molecule 1) abolished inhibitory
16 ons of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, albeit less efficient
17 Ld plus costimulatory ligands, i.e. B7-1 and intercellular adhesion molecule-1 along with 2C T cell r
18                            The expression of intercellular adhesion molecule 1, an NF-kappaB-dependen
19 s and to enhanced cell-surface expression of intercellular adhesion molecule 1 and altered expression
20 stained positive for 2 inflammatory markers, intercellular adhesion molecule 1 and interleukin 8.
21      Unexpectedly, other proteins, including intercellular adhesion molecule 1 and moesin, were selec
22 L oxidation and 2) a significant decrease in intercellular adhesion molecule 1 and OLR1 gene expressi
23                                      Soluble intercellular adhesion molecule 1 and soluble vascular c
24 munoblots were used to measure expression of intercellular adhesion molecule 1 and the inducible form
25 electin, VCAM-1, and KC, while expression of intercellular adhesion molecule 1 and TNF-alpha was supp
26 derived from clustering of apically disposed intercellular adhesion molecule 1 and vascular cell adhe
27 apitulated when a combination of recombinant intercellular adhesion molecule 1 and vascular cell adhe
28 n the luminal surface, such as clustering of intercellular adhesion molecule 1 and vascular cell adhe
29 dies against Macrophage-1 antigen (Mac-1) or intercellular adhesion molecule 1 and were reproduced in
30 h-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 and adjusted for these
31 G2A(-/-) mice and found a 2-fold increase in intercellular adhesion molecule-1 and E-selectin surface
32               Clinical risk factors, soluble intercellular adhesion molecule-1 and endocan (both form
33 [sRAGE]) and endothelial biomarkers (soluble intercellular adhesion molecule-1 and endocan [full-leng
34 ession in G2A(-/-) ECs significantly reduced intercellular adhesion molecule-1 and endothelial select
35 ubset of venules that express high levels of intercellular adhesion molecule-1 and low levels of cave
36 ar endothelial growth factor), and invasion (intercellular adhesion molecule-1 and matrix metalloprot
37 iltration was associated with an increase in intercellular adhesion molecule-1 and RANTES in the aort
38 n, including the metastasis-related proteins intercellular adhesion molecule-1 and urokinase-type pla
39          The lymphatic endothelium expresses intercellular adhesion molecule-1 and vascular adhesion
40 , CCL5, and CCL20 and the adhesion molecules intercellular adhesion molecule-1 and vascular cell adhe
41 re, CB2R agonists decreased the induction of intercellular adhesion molecule-1 and vascular cell adhe
42 alpha receptor II) and endothelial function (intercellular adhesion molecule-1 and vascular cell adhe
43 derived from clustering of apically disposed intercellular adhesion molecule-1 and vascular cell adhe
44           We also measured the expression of intercellular adhesion molecule-1 and vascular cell adhe
45 A1 exon skipping mutations had higher plasma intercellular adhesion molecule-1 and vascular cell adhe
46 ities in soluble adhesion molecules (soluble intercellular adhesion molecule-1 and vascular cellular
47 ng slow neutrophil rolling on E-selectin and intercellular adhesion molecule-1 and were unable to pho
48 uced pulmonary adhesion molecule expression (intercellular adhesion molecule-1) and tissue infiltrati
49 e chemoattractant protein 1) (CCL2), ICAM-1 (intercellular adhesion molecule 1), and dramatic infiltr
50 n), invasion (matrix metalloproteinase-9 and intercellular adhesion molecule-1), and angiogenesis (va
51 phaIIbbeta3 with endothelial alphavbeta3 and intercellular adhesion molecule 1, and (3) a stimulatory
52  4 BCC tumor mRNA markers (CD25, CD3epsilon, intercellular adhesion molecule 1, and CD68) that have b
53 lpha, interleukin (IL)-1beta, IL-6, KC/IL-8, intercellular adhesion molecule 1, and cluster of differ
54 active protein, adiponectin, leptin, soluble intercellular adhesion molecule 1, and E-selectin all fe
55 re of multiple markers [interleukin-6, t-PA, intercellular adhesion molecule 1, and lipoprotein(a)] p
56 s showed increased interleukin (IL)-6, IL-8, intercellular adhesion molecule 1, and platelet endothel
57 f adhesion molecules E-selectin, P-selectin, intercellular adhesion molecule 1, and vascular cell adh
58 elated adhesion molecules (e.g., P-selectin, intercellular adhesion molecule 1, and vascular cell adh
59 lasma levels of tumor necrosis factor-alpha, intercellular adhesion molecule-1, and C-reactive protei
60 A binding activity and protein expression of intercellular adhesion molecule-1, and cytokine-induced
61 rom levels of C-reactive protein and soluble intercellular adhesion molecule-1, and endothelial funct
62 ecules, such as tumor necrosis factor-alpha, intercellular adhesion molecule-1, and MMP9 as well as a
63 ssion of vascular endothelial growth factor, intercellular adhesion molecule-1, and tumor necrosis fa
64 xpression of platelet-derived growth factor, intercellular adhesion molecule-1, and vascular adhesion
65 lation of the adhesion molecules E-selectin, intercellular adhesion molecule-1, and vascular cell adh
66 ntiation, respectively; the plasma levels of intercellular adhesion molecule 1; and CCR6 expression i
67 rs of endothelial adhesion (sICAM-1 [soluble intercellular adhesion molecule 1] and sVCAM-1 [soluble
68 ion of NF-kappaB, which in turn up-regulated intercellular adhesion molecule 1 as evident from chroma
69 ference studies identified interleukin-6 and intercellular adhesion molecule-1 as key NF-kappaB targe
70 r alpha receptor II (B = 0.07, p < .01), and intercellular adhesion molecule-1 (B = 0.04, p < .05) le
71 e function-associated antigen 1) for ICAM-1 (intercellular adhesion molecule 1) but significantly low
72 in alpha(L)beta(2)-dependent slow rolling on intercellular adhesion molecule-1 by activating Src fami
73  also inhibited the TNF-induced induction of intercellular adhesion molecule-1, c-Myc, and c-Fos, all
74 efined as CD146(+)CD45(-)) exhibit increased intercellular adhesion molecule-1 (CD54) and Fas in resp
75 rosis factor-alpha levels as well as cardiac intercellular adhesion molecule-1, cytokine-induced neut
76                          MP uptake is partly intercellular adhesion molecule 1-dependent and leads to
77 induced pulmonary inflammation, with altered intercellular adhesion molecule 1-dependent slow neutrop
78 unds of RW decreased serum concentrations of intercellular adhesion molecule-1, E-selectin, and IL-6
79 expression of NF-kappaB target genes VCAM-1, intercellular adhesion molecule-1, E-selectin, and tissu
80 rial loads were associated with higher serum intercellular adhesion molecule-1, E-selectin, and vascu
81       We hypothesized that the expression of intercellular adhesion molecule-1 even in vessels with h
82 D showed increased endothelial inflammation (intercellular adhesion molecule 1 expression) and increa
83 -1 displayed an attenuated interleukin-6 and intercellular adhesion molecule 1 expression, resulting
84 atter correlated with diastolic function and intercellular adhesion molecule 1 expression.
85 ced tumor necrosis factor (TNF)alpha-induced intercellular adhesion molecule-1 expression and attenua
86  SEB-induced IFN-gamma promoted class II and intercellular adhesion molecule-1 expression by presenti
87 eling-positive cells, TNF-alpha release, and intercellular adhesion molecule-1 expression compared wi
88 tes monocyte adhesion by inducing VCAM-1 and intercellular adhesion molecule-1 expression in endothel
89 leased platelet miR-320b on endothelial cell intercellular adhesion molecule-1 expression was shown.
90 reased vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression, and neutro
91      Removal of P-Rex1 significantly reduced intercellular adhesion molecule-1 expression, polymorpho
92 anism and induced an increase in endothelial intercellular adhesion molecule-1 expression, production
93 helial vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression, reduced in
94                                        HUVEC intercellular adhesion molecule-1 expression, stiffness,
95 treatment failed to inhibit TNFalpha-induced intercellular adhesion molecule-1 expression, treatment
96 nduced vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression.
97 he effect of adiponectin on TNFalpha-induced intercellular adhesion molecule-1 expression.
98 on, and endothelial activation, monitored by intercellular adhesion molecule-1 expression.
99 scular cell adhesion molecule-1) and ICAM-1 (intercellular adhesion molecule-1) expression by endothe
100                MC releasate elevated ICAM-1 (intercellular adhesion molecule-1) expression on HUVEC (
101 selectin, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, fibrinogen-like prote
102 ges have been assumed to mediate adhesion to intercellular adhesion molecule-1 for T-cell conjugation
103  primary sclerosing cholangitis; the role of intercellular adhesion molecule-1 gene polymorphisms and
104 g receptors DC-SIGN (dendritic-cell-specific intercellular adhesion molecule 1-grabbing nonintegrin;
105 evirus A21, an EV with tropism for the human intercellular adhesion molecule 1 (hICAM-1), through ser
106 ondrocytes in this vulnerable zone expressed intercellular adhesion molecule 1 (ICAM-1) (CD54), facil
107  by this E3 ligase in the down regulation of intercellular adhesion molecule 1 (ICAM-1) and B7.2.
108 thelial growth factor (VEGF)), inflammatory (intercellular adhesion molecule 1 (ICAM-1) and cyclooxyg
109  human melanoma cell line (Lu1205) increased intercellular adhesion molecule 1 (ICAM-1) and E-selecti
110                                 We find that intercellular adhesion molecule 1 (ICAM-1) and ICAM-2 on
111 of HTLV-1 p12(I)-mediated down-modulation of intercellular adhesion molecule 1 (ICAM-1) and ICAM-2.
112 e endothelium and in adhesion to immobilized intercellular adhesion molecule 1 (ICAM-1) and vascular
113 ed protein kinases (MAPKs) and expression of intercellular adhesion molecule 1 (ICAM-1) and vascular
114  the proinflammatory cell adhesion molecules intercellular adhesion molecule 1 (ICAM-1) and vascular
115 ction associated antigen 1 (LFA-1) binds the intercellular adhesion molecule 1 (ICAM-1) by its alpha(
116 In this study, the binding affinity of human intercellular adhesion molecule 1 (ICAM-1) chimera and l
117  ezrin/radixin/moesin (ERM) phosphorylation, intercellular adhesion molecule 1 (ICAM-1) clustering, a
118 recognition sequence AGCTCC (-39/-34) in the intercellular adhesion molecule 1 (ICAM-1) core promoter
119    Infected IL-17R-deficient corneas had low intercellular adhesion molecule 1 (ICAM-1) expression, a
120 and thereby dampens NF-kappaB activation and intercellular adhesion molecule 1 (ICAM-1) expression.
121 cular cell adhesion molecule 1 (VCAM-1), and intercellular adhesion molecule 1 (ICAM-1) expression.
122            Nanoparticles (NPs) targeting the intercellular adhesion molecule 1 (ICAM-1) hold promise
123                                              Intercellular adhesion molecule 1 (ICAM-1) is a cell-sur
124                                          The intercellular adhesion molecule 1 (ICAM-1) is induced in
125 moniae-infected macrophages to the aortas of intercellular adhesion molecule 1 (ICAM-1) knockout mice
126 ascular cell adhesion molecule (VCAM-1), and intercellular adhesion molecule 1 (ICAM-1) on endothelia
127 to LLV was able to trigger the clustering of intercellular adhesion molecule 1 (ICAM-1) on endothelia
128 scribed as an inflammatory disease, in which intercellular adhesion molecule 1 (ICAM-1) plays a key r
129 re we show that HDL suppresses expression of intercellular adhesion molecule 1 (ICAM-1) through the t
130 shown to bind to several receptors, of which intercellular adhesion molecule 1 (ICAM-1) upregulation
131 tion between the two groups, lower levels of intercellular adhesion molecule 1 (ICAM-1) were observed
132  the NF-kappaB pathway instantly upregulates intercellular adhesion molecule 1 (ICAM-1) which binds i
133                         This is the case for intercellular adhesion molecule 1 (ICAM-1), a glycoprote
134 ction also increased the cellular content of intercellular adhesion molecule 1 (ICAM-1), a molecule i
135 riety of different host receptors, including intercellular adhesion molecule 1 (ICAM-1), a receptor i
136 ow a group of PfEMP1 proteins interacts with intercellular adhesion molecule 1 (ICAM-1), allowing us
137 rogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-select
138 ocyte function-associated antigen 1 (LFA-1), intercellular adhesion molecule 1 (ICAM-1), and ICAM-3 a
139   Leukocyte infiltration, improved levels of intercellular adhesion molecule 1 (ICAM-1), and oxidativ
140 tenuated the over expression of VEGF and the intercellular adhesion molecule 1 (ICAM-1), and reduced
141 gnificant in only 1 replication set included intercellular adhesion molecule 1 (ICAM-1), anti-LG3, am
142  "outside-in" signaling when bound to ligand intercellular adhesion molecule 1 (ICAM-1), but little i
143  vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), E-selectin,
144 d inflammation: coagulation factor III (F3), intercellular adhesion molecule 1 (ICAM-1), interferon g
145 tu-like expression of cadherins, E-selectin, intercellular adhesion molecule 1 (ICAM-1), vascular cel
146  We examined human effector T lymphocytes on intercellular adhesion molecule 1 (ICAM-1)-coated surfac
147 l host factors impacting protection included intercellular adhesion molecule 1 (ICAM-1)-dependent pol
148  the noninfected target cell in a gp120- and intercellular adhesion molecule 1 (ICAM-1)-dependent pro
149 cell morphology alterations, and crawling on intercellular adhesion molecule 1 (ICAM-1)-expressing ce
150  that is enhanced by the binding of LFA-1 to intercellular adhesion molecule 1 (ICAM-1).
151 nt/beta-catenin signaling in AECs attenuated intercellular adhesion molecule 1 (ICAM-1)/vascular cell
152 d proteins HLA-A, HLA-B, and HLA-C antigens; intercellular adhesion molecule 1 (ICAM-1); S100; transc
153 nregulate MHC-I and PECAM-I but not B7.2 and intercellular adhesion molecule 1 (ICAM-I), consistent w
154 NOS), nuclear factor-kappa B (NF-kappaB) and intercellular adhesion molecule-1 (ICAM) (P < 0.001, res
155 ss adhesion molecules for leukocytes such as intercellular adhesion molecule-1 (ICAM-1 or CD54).
156  of constitutive as well as IL-1beta-induced intercellular adhesion molecule-1 (ICAM-1) (of 55% and 5
157 ) to circulating pro-inflammatory cytokines, intercellular adhesion molecule-1 (ICAM-1) and acute cor
158 f these cells, concomitant with reduction of intercellular adhesion molecule-1 (ICAM-1) and diminishi
159 not Rac1, as critical for B cell adhesion to intercellular adhesion molecule-1 (ICAM-1) and IS format
160  contact points for the known HRV receptors, intercellular adhesion molecule-1 (ICAM-1) and low-densi
161 t3 interaction in correlation with increased intercellular adhesion molecule-1 (ICAM-1) and soluble-I
162 lls, we found that GPx-1 deficiency augments intercellular adhesion molecule-1 (ICAM-1) and vascular
163 otential of these cells through reduction of intercellular adhesion molecule-1 (ICAM-1) and vascular
164 tic cell line THP-1 to a surface coated with intercellular adhesion molecule-1 (ICAM-1) as a function
165 s serotypes, 90% (the major group) use human intercellular adhesion molecule-1 (ICAM-1) as their cell
166 udy was to identify mechanisms through which intercellular adhesion molecule-1 (ICAM-1) augments the
167 endothelium in vitro, an effect countered by intercellular adhesion molecule-1 (ICAM-1) blockade or t
168                                              Intercellular adhesion molecule-1 (ICAM-1) contains five
169                    The Ig superfamily (IgSF) intercellular adhesion molecule-1 (ICAM-1) equilibrates
170                We have previously shown that intercellular adhesion molecule-1 (ICAM-1) expressed by
171 rombin signaling of NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in
172  tumor necrosis factor-alpha (TNF-alpha) and intercellular adhesion molecule-1 (ICAM-1) in aqueous hu
173                 Here, the role of epithelial intercellular adhesion molecule-1 (ICAM-1) in gammadelta
174    Herein, we describe the overexpression of intercellular adhesion molecule-1 (ICAM-1) in human TNBC
175 ntigen-1 (LFA-1) interaction with its ligand intercellular adhesion molecule-1 (ICAM-1) induces a gen
176 sion and display high spontaneous binding to intercellular adhesion molecule-1 (ICAM-1) ligand under
177 yte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1) mediates leuk
178                                              Intercellular adhesion molecule-1 (ICAM-1) mediates the
179  tumor necrosis factor alpha (TNFalpha), and intercellular adhesion molecule-1 (ICAM-1) messenger RNA
180 n species accumulation, CD14 expression, and intercellular adhesion molecule-1 (ICAM-1) mRNA and prot
181 er dynamic flow conditions by the binding of intercellular adhesion molecule-1 (ICAM-1) on melanoma c
182  recognition of pMHC and the adhesion ligand intercellular adhesion molecule-1 (ICAM-1) on supported
183                               P-selectin and intercellular adhesion molecule-1 (ICAM-1) participate i
184 low rolling on E-selectin coimmobilized with intercellular adhesion molecule-1 (ICAM-1) required P-se
185  PfEMP1 and human endothelial proteins CD36, intercellular adhesion molecule-1 (ICAM-1), and endothel
186 tor inhibitor-1, soluble E-selectin, soluble intercellular adhesion molecule-1 (ICAM-1), and soluble
187 iations between plasma levels of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular
188 on sites") surrounded by a field of tethered intercellular adhesion molecule-1 (ICAM-1), as a model s
189 elial migration mediated by a combination of intercellular adhesion molecule-1 (ICAM-1), vascular adh
190 t endothelial adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), vascular adh
191 pha by restraining the induced expression of intercellular adhesion molecule-1 (ICAM-1), vascular cel
192 ion to endothelial cell layers by binding to intercellular adhesion molecule-1 (ICAM-1), which is up-
193 sation requires selectin-mediated tethering, intercellular adhesion molecule-1 (ICAM-1)-dependent fir
194 ogo-B regulates leukocyte transmigration and intercellular adhesion molecule-1 (ICAM-1)-dependent sig
195 ated neutrophils, microglia/macrophages, and intercellular adhesion molecule-1 (ICAM-1)-positive bloo
196 otein that interacts with the host receptor, intercellular adhesion molecule-1 (ICAM-1).
197 ) in a low affinity state to slow rolling on intercellular adhesion molecule-1 (ICAM-1).
198 ression was notable in blood vessels, as was intercellular adhesion molecule-1 (ICAM-1).
199  immunohistochemically for the expression of intercellular adhesion molecule-1 (ICAM-1).
200 of the endothelial mechanosensitive receptor intercellular adhesion molecule-1 (ICAM-1).
201 ociated antigen-1, LFA-1) to slow rolling on intercellular adhesion molecule-1 (ICAM-1).
202 nt with NFkappaB activation and induction of intercellular adhesion molecule-1 (ICAM-1).
203 es by upregulating the inflammatory molecule intercellular adhesion molecule-1 (ICAM-1).
204 protein (LDL) cholesterol, triglyceride, and intercellular adhesion molecule-1 (ICAM-1).
205 kers human leukocyte antigen-DR (HLA-DR) and intercellular adhesion molecule-1 (ICAM-1).
206 dhesion molecules in the vasculature such as intercellular adhesion molecule-1 (ICAM-1).
207 >G), human beta-defensin-1 (DEFB1, 692 G>A), intercellular adhesion molecule-1 (ICAM-1, 1548 A>G), Fa
208 urface proteins, including CD69, L-selectin, intercellular adhesion molecule-1 (ICAM-1, CD54), CD44,
209 or, neutrophil count, IL-1alpha, E-selectin, intercellular adhesion molecule 1 [ICAM-1], myeloperoxid
210                                  Focusing on intercellular adhesion molecule 1(ICAM)-1 as a model, we
211 ng Raman-active molecules were conjugated to intercellular adhesion molecule 1- (ICAM-1-) specific mo
212  in T cells increased expression of IFNG and intercellular adhesion molecule 1 (ICAM1) and induced T-
213 , unlike amphiregulin and TNFRI, full-length intercellular adhesion molecule 1 (ICAM1) is released fr
214 pression of asparaginyl endopeptidase (AEP), intercellular adhesion molecule 1 (ICAM1), and ras-relat
215  monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule 1 (ICAM1), F4/80, plasmi
216 out mice originated from decreased levels of intercellular adhesion molecule 1 (ICAM1)/vascular cell
217 ster of differentiation 8a (Cd8a), Cd14, and intercellular adhesion molecule-1 (Icam1) by about two-f
218 ), leukocytes use adhesion receptors such as intercellular adhesion molecule-1 (ICAM1) to adhere to t
219 ells so modified expressed reduced levels of intercellular adhesion molecule-1 (ICAM1; CD54); blockad
220 IL-6], IL-8, IL-1alpha, CXCL1, CXCL2, CXCL3, intercellular adhesion molecule 1 [ICAM1]), chemoattract
221                                      Soluble intercellular adhesion molecule-1, IFN-lambda1, and eosi
222 reactive protein, interleukin 6, and soluble intercellular adhesion molecule 1 in plasma.
223 activator [tPA]) and endothelial activation (intercellular adhesion molecule-1) in serial biopsies ob
224 the lymphocyte function-associated antigen 1-intercellular adhesion molecule 1 interaction, reduced T
225  signaling were quite distinct so that LFA-1/intercellular adhesion molecule-1 interaction exerted a
226 1alpha (SDF-1alpha)-stimulated LFA-1-ICAM-1 (intercellular adhesion molecule-1) interactions and LFA-
227 ated positively with lipoprotein(a) (Lp[a]), intercellular adhesion molecule 1, interleukin-6, and ho
228 nd inflammatory markers [C-reactive protein, intercellular adhesion molecule-1, interleukin-6, and tu
229 ) related to C-reactive protein, fibrinogen, intercellular adhesion molecule-1, interleukin-6, P-sele
230 th factor beta1 and beta2; thrombospondin 2; intercellular adhesion molecule 1; interleukin 6 [IL-6];
231 e tumor necrosis factor receptor II, soluble intercellular adhesion molecule 1, leptin, and adiponect
232 high-sensitivity C-reactive protein, soluble intercellular adhesion molecule-1, leptin, hemoglobin A(
233 antibody crosslinking or by crosslinking its intercellular adhesion molecule-1 ligand on the supporte
234 anulocyte colony-stimulating factor, soluble intercellular adhesion molecule 1, macrophage migration-
235 osis protein-2, cyclin D1, cyclooxygenase-2, intercellular adhesion molecule-1, matrix metalloprotein
236    Model 3 identified a set of 6 biomarkers (intercellular adhesion molecule-1, matrix metalloprotein
237 iomarkers strongly associated with death/MI: intercellular adhesion molecule-1, matrix metalloprotein
238 nduced expression of MHC-I, MHC-II, and CD54/intercellular adhesion molecule 1 molecules.
239 but involved class II histocompatibility and intercellular adhesion molecule 1 molecules.
240 enofibrate also attenuated overexpression of intercellular adhesion molecule-1, monocyte chemoattract
241 ession of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, monocyte chemoattract
242 ses in vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 mRNA expression in the
243 ut reduced expression or secretion of T-bet, intercellular adhesion molecule-1, nucleotide-binding ol
244 cantly increased KC numbers via induction of intercellular adhesion molecule 1 on liver sinusoidal en
245 olved beta2 integrins on eosinophils but not intercellular adhesion molecule-1 on human HCEs.
246                                              Intercellular adhesion molecule-1 on melanoma cells and
247 ls of plasma endothelial biomarkers (soluble intercellular adhesion molecule-1: OR, 1.58; 95% CI, 1.2
248 vels correlated with serum levels of soluble intercellular adhesion molecule-1 (p = 0.001) and thioba
249 ting levels of vascular adhesion molecule-1, intercellular adhesion molecule-1, P-selectin, non-invas
250 selectin, vascular cell adhesion molecule 1, intercellular adhesion molecule 1, platelet endothelial
251                                     Blocking intercellular adhesion molecule-1 prevents cellular egre
252 ecrosis factor receptor II (r=0.22), soluble intercellular adhesion molecule 1 (r=0.24), and leptin (
253 ceptor-2, vascular cell adhesion molecule 1, intercellular adhesion molecule 1, selectins, and integr
254 s, hepatic decompensation, and soluble serum intercellular adhesion molecule 1 (sICAM-1) MFI.
255 ha receptor 2 (sTNF-R2), E-selectin, soluble intercellular adhesion molecule 1 (sICAM-1), and soluble
256 otein (hs-CRP), adiponectin, leptin, soluble intercellular adhesion molecule 1 (sICAM-1), soluble vas
257  the prospective association between soluble intercellular adhesion molecule-1 (sICAM-1) and cancer r
258 dence of proliferative DR (PDR), and soluble intercellular adhesion molecule-1 (sICAM-1) and TNF-alph
259 active protein (CRP), serum amyloid A (SAA), intercellular adhesion molecule-1 (sICAM-1) and vascular
260 vity C-reactive protein, fibrinogen, soluble intercellular adhesion molecule-1 (sICAM-1), homocystein
261 e measured levels of UA and soluble forms of intercellular adhesion molecule-1 (sICAM-1), vascular ce
262 dothelial activation (E-selectin and soluble intercellular adhesion molecule-1 [sICAM-1]), and thromb
263  and IL-6, and serum levels of IL-6, soluble intercellular adhesion molecule 1 (sICAM1), 8-isoprostan
264 generate polyplexes carrying siRNA targeting intercellular adhesion molecule-1 (siICAM-1).
265 or-alpha receptor II, interleukin-6, soluble intercellular adhesion molecule 1, soluble vascular cell
266 sitivity C-reactive protein, fibrinogen, and intercellular adhesion molecule-1, suggested that GlycA
267 microscopy and contrast-enhanced ultrasound, intercellular adhesion molecule-1-targeted and rhodamine
268                                              Intercellular adhesion molecule-1-targeted and rhodamine
269 s were translatable in vivo, confirming that intercellular adhesion molecule-1-targeted and rhodamine
270 or necrosis factor-alpha, interleukin-6, and intercellular adhesion molecule-1, than iron-overloaded
271 es produced greater levels of chemokines and intercellular adhesion molecule-1 that are associated wi
272 he capsid that caused a receptor switch from intercellular adhesion molecule-1 to CD155, leading to a
273                                   Binding of intercellular adhesion molecule-1 to the beta2-integrin
274 tterns of interleukin-1 receptor antagonist, intercellular adhesion molecule-1, tumor necrosis factor
275  spleen tyrosine kinase and cell adhesion to intercellular adhesion molecule-1 under dynamic flow.
276 orrelated with IL-6, soluble TNF receptor 2, intercellular adhesion molecule 1, vascular adhesion mol
277 ld increase in the expression of E-selectin, intercellular adhesion molecule 1, vascular cell adhesio
278 ecreted levels of the proangiogenic proteins intercellular adhesion molecule-1, vascular cell adhesio
279 (tumor necrosis factor-alpha, interleukin-6, intercellular adhesion molecule-1, vascular cell adhesio
280 gamma), endothelial cell adhesion molecules (intercellular adhesion molecule-1, vascular cell adhesio
281 ay and expression of cell adhesion molecules intercellular adhesion molecule-1, vascular cell adhesio
282 , enhanced expression of adhesion molecules (intercellular adhesion molecule-1, vascular cell adhesio
283 tion of retinal tumor necrosis factor-alpha, intercellular adhesion molecule-1, vascular cell adhesio
284  reduced or absent expression of P-selectin, intercellular adhesion molecule-1, vascular cell adhesio
285                       In human lung tissues, intercellular adhesion molecule-1, vascular cell adhesio
286 e chemotactic protein-1, C-reactive protein, intercellular adhesion molecule-1, vascular cell adhesio
287 nts had significantly lower plasma levels of intercellular adhesion molecule-1, von Willebrand factor
288 the expression of endothelial E-selectin and intercellular adhesion molecule 1 was decreased by eithe
289 and expression of constitutive and inducible intercellular adhesion molecule-1 was significantly high
290  6, tumor necrosis factor alpha, and soluble intercellular adhesion molecule 1 were measured.
291 g/L (P<0.0001), and median levels of soluble intercellular adhesion molecule-1 were 374 versus 333 ng
292 h-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 were added to multivar
293 n-8, monocyte chemoattactrant protein-1, and intercellular adhesion molecule-1 were analyzed after tr
294 n 6, tumor necrosis factor alpha and soluble intercellular adhesion molecule 1) were unsuitable for p
295 ascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1) were measured.
296 vascular cell adhesion molecule (VCAM)-1 and intercellular adhesion molecule-1, whereas NOR1 deficien
297 sinophils also showed enhanced expression of intercellular adhesion molecule 1, which depended on dir
298 s also associated with the overexpression of intercellular adhesion molecule 1, which is expressed on
299 ncluding inducible nitric-oxide synthase and intercellular adhesion molecule-1, which was decreased b
300  increased progression risk, and increase in intercellular adhesion molecule 1 with vandetanib was as

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top